A pH-sensitive heparin-binding sequence from baculovirus gp64 protein is important for binding to mammalian cells but not to Sf9 insect cells

Journal of Virology

Volumn 86, Issue 1, 2012, Pages 484-491

  Wu, Chunxiao ^a   Wanga, Shu ^a,b  

^a INSTITUTE OF BIOENGINEERING AND NANOTECHNOLOGY   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARAN SULFATE; HEPARIN LYASE; PROTEIN GP64; UNCLASSIFIED DRUG; VIRUS PROTEIN;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; BACULOVIRUS; CELL ADHESION; CELL SURFACE; CONTROLLED STUDY; FLUORESCENCE ANALYSIS; GLIOMA CELL; HUMAN; HUMAN CELL; INSECT CELL; NONHUMAN; PH MEASUREMENT; PRIORITY JOURNAL; PROTEIN BINDING; VIRUS ATTACHMENT; VIRUS CELL INTERACTION; VIRUS TRANSMISSION; VIRUS VIRULENCE;

AMINO ACID MOTIFS; AMINO ACID SEQUENCE; ANIMALS; CELL LINE; GENETIC VECTORS; HEPARITIN SULFATE; HUMANS; HYDROGEN-ION CONCENTRATION; MAMMALS; MOLECULAR SEQUENCE DATA; NUCLEOPOLYHEDROVIRUS; PROTEIN BINDING; RECEPTORS, VIRUS; SPODOPTERA; TRANSDUCTION, GENETIC; VIRAL ENVELOPE PROTEINS;

HEXAPODA; MAMMALIA;

EID: 84862908781     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.06357-11     Document Type: Article

References (51)

1. Balani P, et al. 2009. High mobility group box2 promoter-controlled suicide gene expression enables targeted glioblastoma treatment. Mol. Ther. 17: 1003-1011.
2. Blissard GW. 1996. Baculovirus-insect cell interactions. Cytotechnology 20: 73-93.
3. Blissard GW, Wenz JR. 1992. Baculovirus gp64 envelope glycoprotein is sufficient to mediate pH-dependent membrane fusion. J. Virol. 66: 6829-6835.
4. Borza DB, Morgan WT. 1998. Histidine-proline-rich glycoprotein as a plasma pH sensor. Modulation of its interaction with glycosaminoglycans by pH and metals. J. Biol. Chem. 273: 5493-5499.
5. Cardin AD, Weintraub HJ. 1989. Molecular modeling of proteinglycosaminoglycan interactions. Arteriosclerosis 9: 21-32.
6. Chen Y, et al. 1997. Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate. Nat. Med. 3: 866-871.
7. Dash PR, Read ML, Barrett LB, Wolfert MA, Seymour LW. 1999. Factors affecting blood clearance and in vivo distribution of polyelectrolyte complexes for gene delivery. Gene Ther. 6: 643-650.
8. Dechecchi MC, Tamanini A, Bonizzato A, Cabrini G. 2000. Heparan sulfate glycosaminoglycans are involved in adenovirus type 5 and 2-host cell interactions. Virology 268: 382-390.
9. Duisit G, et al. 1999. Baculovirus vector requires electrostatic interactions including heparan sulfate for efficient gene transfer in mammalian cells. J. Gene Med. 1: 93-102.
10. Ernst WJ, Spenger A, Toellner L, Katinger H, Grabherr RM. 2000. Expanding baculovirus surface display. Modification of the native coat protein gp64 of Autographa californica NPV. Eur. J. Biochem. 267: 4033-4039.
11. Giroglou T, Florin L, Schafer F, Streeck RE, Sapp M. 2001. Human papillomavirus infection requires cell surface heparan sulfate. J. Virol. 75: 1565-1570.
12. Grace TDC. 1962. Establishment of four strains of cells from insect tissue grown in vitro. Nature 195: 788 -789.
13. Hefferon KL, Oomens AG, Monsma SA, Finnerty CM, Blissard GW. 1999. Host cell receptor binding by baculovirus GP64 and kinetics of virion entry. Virology 258: 455-468.
14. Heldwein EE, et al. 2006. Crystal structure of glycoprotein B from herpes simplex virus 1. Science 313: 217-220.
15. Hondal RJ, Ma S, Caprioli RM, Hill KE, Burk RF. 2001. Heparinbinding histidine and lysine residues of rat selenoprotein P. J. Biol. Chem. 276: 15823-15831.
16. Ibrahim J, Griffin P, Coombe DR, Rider CC, James W. 1999. Cellsurface heparan sulfate facilitates human immunodeficiency virus type 1 entry into some cell lines but not primary lymphocytes. Virus Res. 60: 159-169.
17. Ignatovich IA, et al. 2003. Complexes of plasmid DNA with basic domain 47-57 of the HIV-1 Tat protein are transferred to mammalian cells by endocytosis-mediated pathways. J. Biol. Chem. 278: 42625-42636.
18. Jarousse N, Chandran B, Coscoy L. 2008. Lack of heparan sulfate expression in B-cell lines: implications for Kaposi's sarcoma-associated herpesvirus and murine gammaherpesvirus 68 infections. J. Virol. 82: 12591-12597.
19. Jones KS, Petrow-Sadowski C, Bertolette DC, Huang Y, Ruscetti FW. 2005. Heparan sulfate proteoglycans mediate attachment and entry of human T-cell leukemia virus type 1 virions into CD4+ T cells. J. Virol. 79: 12692-12702.
20. Kadlec J, Loureiro S, Abrescia NG, Stuart DI, Jones IM. 2008. The postfusion structure of baculovirus gp64 supports a unified view of viral fusion machines. Nat. Struct. Mol. Biol. 15: 1024 -1030.
21. Kost TA, Condreay JP. 2002. Recombinant baculoviruses as mammalian cell gene-delivery vectors. Trends Biotechnol. 20: 173-180.
22. Kumar M, Bradow BP, Zimmerberg J. 2003. Large-scale production of pseudotyped lentiviral vectors using baculovirus GP64. Hum. Gene Ther. 14: 67-77.
23. Lohse DL, Linhardt RJ. 1992. Purification and characterization of heparin lyases from Flavobacterium heparinum. J. Biol. Chem. 267: 24347-24355.
24. Margalit H, Fischer N, Ben-Sasson SA. 1993. Comparative analysis of structurally defined heparin binding sequences reveals a distinct spatial distribution of basic residues. J. Biol. Chem. 268: 19228 -19231.
25. Markovic I, Pulyaeva H, Sokoloff A, Chernomordik LV. 1998. Membrane fusion mediated by baculovirus gp64 involves assembly of stable gp64 trimers into multiprotein aggregates. J. Cell Biol. 143: 1155-1166.
26. Monsma SA, Blissard GW. 1995. Identification of a membrane fusion domain and an oligomerization domain in the baculovirus GP64 envelope fusion protein. J. Virol. 69: 2583-2595.
27. Morse MA, Marriott AC, Nuttall PA. 1992. The glycoprotein of Thogoto virus (a tick-borne orthomyxo-like virus) is related to the baculovirus glycoprotein GP64. Virology 186: 640-646.
28. Ogris M, Brunner S, Schuller S, Kircheis R, Wagner E. 1999. PEGylated DNA/transferrin-PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery. Gene Ther. 6: 595-605.
29. Oomens AG, Monsma SA, Blissard GW. 1995. The baculovirus GP64 envelope fusion protein: synthesis, oligomerization, and processing. Virology 209: 592-603.
30. Pearson MN, Rohrmann GF. 2002. Transfer, incorporation, and substitution of envelope fusion proteins among members of the Baculoviridae, Orthomyxoviridae, and Metaviridae (insect retrovirus) families. J. Virol. 76: 5301-5304.
31. Pennock GD, Shoemaker C, Miller LK. 1984. Strong and regulated expression of Escherichia coli beta-galactosidase in insect cells with a baculovirus vector. Mol. Cell. Biol. 4: 399-406.
32. Pinon JD, et al. 2003. Human T-cell leukemia virus type 1 envelope glycoprotein gp46 interacts with cell surface heparan sulfate proteoglycans. J. Virol. 77: 9922-9930.
33. Roche S, Bressanelli S, Rey FA, Gaudin Y. 2006. Crystal structure of the low-pH form of the vesicular stomatitis virus glycoprotein G. Science 313: 187-191.
34. Schauber CA, Tuerk MJ, Pacheco CD, Escarpe PA, Veres G. 2004. Lentiviral vectors pseudotyped with baculovirus gp64 efficiently transduce mouse cells in vivo and show tropism restriction against hematopoietic cell types in vitro. Gene Ther. 11: 266 -275.
35. Sobel M, Soler DF, Kermode JC, Harris RB. 1992. Localization and characterization of a heparin binding domain peptide of human von Willebrand factor. J. Biol. Chem. 267: 8857-8862.
36. Spear PG, Longnecker R. 2003. Herpesvirus entry: an update. J. Virol. 77: 10179 -10185.
37. Spenger A, Grabherr R, Tollner L, Katinger H, Ernst W. 2002. Altering the surface properties of baculovirus Autographa californica NPV by insertional mutagenesis of the envelope protein gp64. Eur. J. Biochem. 269: 4458-4467.
38. Spillmann D. 2001. Heparan sulfate: anchor for viral intruders? Biochimie 83: 811-817.
39. Summers MD, Volkman LE. 1976. Comparison of biophysical and morphological properties of occluded and extracellular nonoccluded baculovirus from in vivo and in vitro host systems. J. Virol. 17: 962-972.
40. Verrecchio A, et al. 2000. Design of peptides with high affinities for heparin and endothelial cell proteoglycans. J. Biol. Chem. 275: 7701-7707.
41. Volkman LE, Goldsmith PA. 1985. Mechanism of neutralization of budded Autographa californica nuclear polyhedrosis virus by a monoclonal antibody: inhibition of entry by adsorptive endocytosis. Virology 143: 185-195.
42. Vongchan P, Linhardt RJ. 2007. Expression of human liver HSPGs on acute myeloid leukemia. Clin. Immunol. 122: 194 -206.
43. Vyas AA, et al. 1997. Analysis of binding of cobra cardiotoxins to heparin reveals a new beta-sheet heparin-binding structural motif. J. Biol. Chem. 272: 9661-9670.
44. Wang CY, et al. 2006. Recombinant baculovirus containing the diphtheria toxin A gene for malignant glioma therapy. Cancer Res. 66: 5798 -5806.
45. Wang CY, Wang S. 2005. Adeno-associated virus inverted terminal repeats improve neuronal transgene expression mediated by baculoviral vectors in rat brain. Hum. Gene Ther. 16: 1219-1226.
46. Wittrup A, et al. 2009. ScFv antibody-induced translocation of cellsurface heparan sulfate proteoglycan to endocytic vesicles: evidence for heparan sulfate epitope specificity and role of both syndecan and glypican. J. Biol. Chem. 284: 32959 -32967.
47. Wu C, et al. 2009. Combinatorial control of suicide gene expression by tissue-specific promoter and microRNA regulation for cancer therapy. Mol. Ther. 17: 2058-2066.
48. Wu C, Soh KY, Wang S. 2007. Ion-exchange membrane chromatography method for rapid and efficient purification of recombinant baculovirus and baculovirus gp64 protein. Hum. Gene Ther. 18: 665-672.
49. Zeng J, Du J, Zhao Y, Palanisamy N, Wang S. 2007. Baculoviral vectormediated transient and stable transgene expression in human embryonic stem cells. Stem Cells 25: 1055-1061.
50. Zhou J, Blissard GW. 2008. Identification of a GP64 subdomain involved in receptor binding by budded virions of the baculovirus Autographa californica multicapsid nucleopolyhedrovirus. J. Virol. 82: 4449-4460.
51. Zhou J, Blissard GW. 2006. Mapping the conformational epitope of a neutralizing antibody (AcV1) directed against the AcMNPV GP64 protein. Virology 352: 427-437.